Fresenius Medical Care AG & Co. KGaA (ETR:FME) receives a price target of €23.00 from analysts at JPMorgan Chase & Co.

0

Fresenius Medical Care AG & Co. KGaA (ETR: FMEGet a rating) received a price target of €23.00 ($23.47) from research analysts at JPMorgan Chase & Co. in a report released on Friday, Borsen Zeitung reports. JPMorgan Chase & Co.The company’s price target would suggest a potential decline of 36.38% from the company’s current price.

A number of other brokerages have also recently released reports on FME. Warburg Research set a price target of €42.00 ($42.86) on Fresenius Medical Care AG & Co. KGaA in a Friday, August 5 research note. UBS Group set a target price of €38.00 ($38.78) on Fresenius Medical Care AG & Co. KGaA in a Friday, July 29 report. Deutsche Bank Aktiengesellschaft set a target price of €37.00 ($37.76) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, August 2 report. Berenberg Bank set a target price of €57.95 ($59.13) on Fresenius Medical Care AG & Co. KGaA in a Monday, August 8 report. Finally, Credit Suisse Group set a target price of €47.00 ($47.96) on Fresenius Medical Care AG & Co. KGaA in a Friday, August 5 report.

Fresenius Medical Care AG & Co. KGaA trades up 0.7%

Shares of Action Fresenius Medical Care AG & Co. KGaA open at €36.15 ($36.89) on Friday. Fresenius Medical Care AG & Co. KGaA has a 52-week minimum of €35.08 ($35.80) and a 52-week maximum of €69.96 ($71.39). The stock’s 50-day simple moving average is €43.74 and its 200-day simple moving average is €53.41. The stock has a market capitalization of $10.61 billion and a P/E ratio of 13.15. The company has a debt ratio of 88.41, a quick ratio of 0.70 and a current ratio of 1.18.

About Fresenius Medical Care AG & Co. KGaA

(Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Featured Articles



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.